{"id":"standard-diuretic-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypokalemia (low potassium)"},{"rate":null,"effect":"Hyperuricemia (elevated uric acid)"},{"rate":null,"effect":"Hyperglycemia (elevated blood glucose)"},{"rate":null,"effect":"Hypotension (low blood pressure)"},{"rate":null,"effect":"Dehydration"},{"rate":null,"effect":"Electrolyte imbalances"}]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Diuretics work by blocking ion transporters in the nephron (loop of Henle, distal convoluted tubule, or collecting duct depending on class) to prevent reabsorption of sodium, chloride, and water. This reduces circulating blood volume and lowers blood pressure, making them useful for managing hypertension, edema, and heart failure. The specific mechanism varies by diuretic class (thiazide, loop, potassium-sparing, or osmotic).","oneSentence":"Standard diuretic therapy increases urine output and reduces fluid volume in the body by inhibiting sodium and water reabsorption in the kidneys.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:03.772Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Edema associated with heart failure, liver cirrhosis, or renal disease"},{"name":"Congestive heart failure"}]},"trialDetails":[{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT05677100","phase":"NA","title":"Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure","status":"RECRUITING","sponsor":"Procyrion","startDate":"2023-08-23","conditions":"Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome","enrollment":320},{"nctId":"NCT07481097","phase":"NA","title":"Hemodynamic Resuscitation Guided by Non-Invasive Mean Systemic Filling Pressure to Prevent Acute Kidney Injury in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-01","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":100},{"nctId":"NCT07469722","phase":"PHASE2, PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":"Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect","enrollment":128},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07444203","phase":"","title":"Transformative Research in Diabetic Nephropathy 2.0","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-11-12","conditions":"Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic","enrollment":200},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT07422948","phase":"NA","title":"Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-05","conditions":"Acute on Chronic Liver Failure","enrollment":113},{"nctId":"NCT06921603","phase":"NA","title":"POCUS-Guided Diuresis for Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-06-29","conditions":"Heart Decompensation, Acute, Acute Kidney Injuries","enrollment":588},{"nctId":"NCT06381934","phase":"NA","title":"Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-05-06","conditions":"Thiazide Associated Hyponatremia","enrollment":136},{"nctId":"NCT05780710","phase":"NA","title":"OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake","status":"RECRUITING","sponsor":"Aktiia SA","startDate":"2023-06-29","conditions":"Hypertension","enrollment":35},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":"Heart Failure, Diabete Type 2, Arterial Hypertension","enrollment":120},{"nctId":"NCT03892148","phase":"PHASE4","title":"Protocol of Diuretics Use in Congestive Therapy in Heart Failure","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-05-17","conditions":"Heart Failure, Acute Heart Failure, Chronic Heart Failure","enrollment":299},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT07335900","phase":"NA","title":"A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-12-19","conditions":"Severe Aortic Valve Stenosis","enrollment":25},{"nctId":"NCT07334197","phase":"NA","title":"Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-12-20","conditions":"Ppm, Cardiomyopathy","enrollment":25},{"nctId":"NCT04691700","phase":"PHASE4","title":"GOREISAN for Heart Failure (GOREISAN-HF) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeshi Morimoto","startDate":"2021-01-19","conditions":"Heart Failure, Edema, Traditional Japanese Medicine","enrollment":1179},{"nctId":"NCT06696235","phase":"PHASE4","title":"Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-12-31","conditions":"Cardiogenic Shock, Acute Kidney Injury","enrollment":408},{"nctId":"NCT07315139","phase":"NA","title":"Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-02-01","conditions":"Pentoxifylline, Inflammatory Markers, Non-Diabetic","enrollment":42},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT04481919","phase":"PHASE2","title":"Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-01","conditions":"Heart Failure, Acute Heart Failure","enrollment":474},{"nctId":"NCT05253287","phase":"PHASE2, PHASE3","title":"Growth Hormone in Decompensated Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-02-01","conditions":"Liver Cirrhosis, Fibrosis, End Stage Liver Disease","enrollment":96},{"nctId":"NCT07262723","phase":"PHASE2, PHASE3","title":"Levosimendan in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Chittagong Medical College","startDate":"2025-12-01","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":332},{"nctId":"NCT05732727","phase":"PHASE3","title":"Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease","status":"RECRUITING","sponsor":"University Hospital, Tours","startDate":"2023-03-28","conditions":"Chronic Kidney Disease(CKD), Uncontrolled Hypertension","enrollment":720},{"nctId":"NCT07199088","phase":"NA","title":"Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-10-11","conditions":"Acute Decompensated Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic","enrollment":320},{"nctId":"NCT07175948","phase":"","title":"Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-06-01","conditions":"Myocarditis, Myocarditis Acute","enrollment":100},{"nctId":"NCT07173426","phase":"NA","title":"Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure","status":"RECRUITING","sponsor":"Mid and South Essex NHS Foundation Trust","startDate":"2024-12-30","conditions":"Heart Failure, Decompensated Heart Failure","enrollment":255},{"nctId":"NCT07076615","phase":"PHASE4","title":"The Effect of Dapagliflozin on Patients With Cardiomyopathy","status":"RECRUITING","sponsor":"May Mohamed Abdalla","startDate":"2025-08","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":100},{"nctId":"NCT07099885","phase":"NA","title":"Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2025-08-01","conditions":"Acute Heart Failure (AHF), Congestion, Venous","enrollment":90},{"nctId":"NCT07086287","phase":"NA","title":"Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Anhui Medical University","startDate":"2025-08-01","conditions":"After Cardiac Surgery, Diuretic Resistance","enrollment":120},{"nctId":"NCT05528588","phase":"PHASE2","title":"Furoscix in Heart Failure Patients With Diuretic Resistance","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-06-02","conditions":"Heart Failure","enrollment":70},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT07022314","phase":"","title":"Urine Output Response to Fluid and Diuretic Therapy in Cardiac ICU Patients Monitored With FIZE kUO®","status":"NOT_YET_RECRUITING","sponsor":"FIZE Medical ltd","startDate":"2025-07","conditions":"AKI - Acute Kidney Injury, Cardiac Surgery, Fluid Therapy","enrollment":45},{"nctId":"NCT04206501","phase":"NA","title":"OptiVol for Precision Medical Management of Heart Failure","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2020-02-05","conditions":"Ischemic and Non-ischemic Cardiomyopathy","enrollment":7},{"nctId":"NCT03928158","phase":"PHASE2","title":"LCZ696 in Advanced LV Hypertrophy and HFpEF","status":"COMPLETED","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2019-05-31","conditions":"Heart Failure, Essential Hypertension","enrollment":61},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT03107416","phase":"PHASE1, PHASE2","title":"Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-04-05","conditions":"Unresectable Hepatocellular Carcinoma","enrollment":30},{"nctId":"NCT06576934","phase":"NA","title":"Early TIPS in Patients With Liver Cirrhosis and Ascites","status":"RECRUITING","sponsor":"University Hospital Freiburg","startDate":"2025-04-01","conditions":"Liver Cirrhosis, Ascites Hepatic, Portal Hypertension","enrollment":134},{"nctId":"NCT06919523","phase":"PHASE2","title":"Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2025-04-15","conditions":"Refractory Ascites","enrollment":70},{"nctId":"NCT05797558","phase":"NA","title":"Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2023-04-28","conditions":"Primary Hyperaldosteronism Due to Adrenal Adenoma","enrollment":80},{"nctId":"NCT05015764","phase":"NA","title":"Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2021-04-12","conditions":"Heart Failure","enrollment":31},{"nctId":"NCT06887179","phase":"NA","title":"Point-of-Care Ultrasound in Chronic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Masaryk University","startDate":"2025-04-01","conditions":"Cardiovascular Diseases","enrollment":112},{"nctId":"NCT05057572","phase":"NA","title":"Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-10-01","conditions":"Liver Cirrhosis","enrollment":104},{"nctId":"NCT05795400","phase":"NA","title":"Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2022-06-01","conditions":"Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction","enrollment":50},{"nctId":"NCT05976139","phase":"NA","title":"Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies","status":"RECRUITING","sponsor":"Fondazione G.B. Bietti, IRCCS","startDate":"2023-09-06","conditions":"Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy","enrollment":10},{"nctId":"NCT06166654","phase":"PHASE4","title":"Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2024-09-05","conditions":"Acute Heart Failure","enrollment":939},{"nctId":"NCT05986773","phase":"PHASE4","title":"Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance","status":"TERMINATED","sponsor":"Stadtspital Zürich","startDate":"2023-10-10","conditions":"Acute Heart Failure, Diuretic Resistance","enrollment":13},{"nctId":"NCT04893733","phase":"PHASE4","title":"Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI","status":"COMPLETED","sponsor":"Caja Nacional de Salud","startDate":"2020-09-01","conditions":"Acute Kidney Injury","enrollment":260},{"nctId":"NCT06799910","phase":"NA","title":"Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2024-09-26","conditions":"Congestion, RRT, UF","enrollment":60},{"nctId":"NCT06783166","phase":"PHASE2, PHASE3","title":"Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-08-15","conditions":"Acute Heart Failure","enrollment":100},{"nctId":"NCT06377449","phase":"NA","title":"Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients","status":"RECRUITING","sponsor":"Saint Petersburg State University, Russia","startDate":"2024-05-15","conditions":"Ischemic Heart Disease, Aortic Stenosis, Severe, Aortic Insufficiency","enrollment":186},{"nctId":"NCT06495892","phase":"PHASE4","title":"PVP-Guided Decongestive Therapy in HF 2","status":"RECRUITING","sponsor":"Başakşehir Çam & Sakura City Hospital","startDate":"2024-07-01","conditions":"Heart Failure, Congestion, Congestive Heart Failure","enrollment":650},{"nctId":"NCT03302910","phase":"NA","title":"Short Stay Unit vs Hospitalization in Acute Heart Failure","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-12-06","conditions":"Acute Heart Failure","enrollment":194},{"nctId":"NCT03505788","phase":"PHASE4","title":"Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2018-11-11","conditions":"Acute Decompensated Heart Failure, Volume Overload","enrollment":519},{"nctId":"NCT06652087","phase":"NA","title":"Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction","status":"RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2024-09-02","conditions":"Bacterial Overgrowth Syndrome Small Bowel, Heart Failure with Preserved Ejection Fraction","enrollment":40},{"nctId":"NCT05849766","phase":"PHASE3","title":"Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction","status":"COMPLETED","sponsor":"October 6 University","startDate":"2023-04-27","conditions":"Dilated Cardiomyopathy","enrollment":150},{"nctId":"NCT06629246","phase":"NA","title":"Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure with Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Chongqing Traditional Chinese Medicine Hospital","startDate":"2021-09-01","conditions":"Heart Failure, Diastolic (HFpEF)","enrollment":100},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT06535529","phase":"PHASE3","title":"Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients","status":"RECRUITING","sponsor":"Helwan University","startDate":"2024-08-24","conditions":"Acute Decompensated Heart Failure","enrollment":60},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT04549701","phase":"NA","title":"Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure","status":"COMPLETED","sponsor":"Instituto Cardiovascular de Buenos Aires","startDate":"2022-03-20","conditions":"Heart Failure, Acute Heart Failure","enrollment":60},{"nctId":"NCT03136198","phase":"PHASE2","title":"B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-07-10","conditions":"Heart Failure, Heart Failure Acute, Acute Cardiac Pulmonary Edema","enrollment":130},{"nctId":"NCT04112199","phase":"PHASE2","title":"A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites","status":"TERMINATED","sponsor":"BioVie Inc.","startDate":"2021-06-17","conditions":"Ascites, Decompensated Cirrhosis","enrollment":15},{"nctId":"NCT05084534","phase":"NA","title":"Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.","status":"WITHDRAWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-11-01","conditions":"Refractory Ascites in Children With Cirrhosis","enrollment":""},{"nctId":"NCT04606927","phase":"NA","title":"Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2021-02-01","conditions":"Heart Failure Acute","enrollment":310},{"nctId":"NCT04298229","phase":"PHASE3","title":"Efficacy and Safety of Dapagliflozin in Acute Heart Failure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-04-01","conditions":"Heart Failure, Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT06278792","phase":"NA","title":"Readily Available Urinary Sodium Analysis in Patients With Acute Decompensated Heart Failure","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2022-03-07","conditions":"Acute Decompensated Heart Failure","enrollment":60},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT06242938","phase":"NA","title":"Early Intensive Antihypertensive Treatment in High-Risk Population of intraCerebral Hemorrhage ExpanSion Predicted by Artificial Intelligence","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2024-02-15","conditions":"Cerebral Hemorrhage","enrollment":680},{"nctId":"NCT06218199","phase":"PHASE4","title":"Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts","status":"RECRUITING","sponsor":"Heart Center Research, LLC","startDate":"2021-07-08","conditions":"Heart Failure, Congestive","enrollment":80},{"nctId":"NCT06224075","phase":"NA","title":"Task-specific Training for Patients With Acute Exacerbation of COPD","status":"UNKNOWN","sponsor":"Universidad de Granada","startDate":"2024-01-15","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":68},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT06155760","phase":"NA","title":"Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2023-11-25","conditions":"Severe Alcoholic Hepatitis","enrollment":150},{"nctId":"NCT05809011","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)","status":"UNKNOWN","sponsor":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","startDate":"2023-04-24","conditions":"Acute Heart Failure","enrollment":120},{"nctId":"NCT03967717","phase":"","title":"Correlation of Clinical and Laboratory Findings and Diuretic Efficacy in Patients With Edematous States in the Emergency Department","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2019-06-28","conditions":"Edema","enrollment":102},{"nctId":"NCT05186428","phase":"NA","title":"Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase","status":"UNKNOWN","sponsor":"Poitiers University Hospital","startDate":"2022-04-06","conditions":"Diuresis in Incontinent Patients","enrollment":80},{"nctId":"NCT06102031","phase":"NA","title":"Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-11","conditions":"Heart Failure","enrollment":1000},{"nctId":"NCT06080802","phase":"PHASE2, PHASE3","title":"The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction","status":"UNKNOWN","sponsor":"October University for Modern Sciences and Arts","startDate":"2023-11-01","conditions":"Heart Failure With Preserved Ejection Fraction, Diabete Type 2","enrollment":80},{"nctId":"NCT05287100","phase":"NA","title":"To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-01","conditions":"Cirrhosis, Liver","enrollment":35},{"nctId":"NCT04855097","phase":"NA","title":"Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure","status":"COMPLETED","sponsor":"Daxor Corporation","startDate":"2022-05-01","conditions":"Acute Decompensated Heart Failure","enrollment":32},{"nctId":"NCT06026787","phase":"PHASE4","title":"Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-08-01","conditions":"Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors","enrollment":60},{"nctId":"NCT05940220","phase":"PHASE3","title":"Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2023-12-30","conditions":"Heart Failure","enrollment":130},{"nctId":"NCT03775759","phase":"NA","title":"Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-08-22","conditions":"Tricuspid Valve Insufficiency, Right Heart Failure, Heart Failure","enrollment":71},{"nctId":"NCT03420144","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy in Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2018-01-15","conditions":"Cirrhosis, Liver","enrollment":76},{"nctId":"NCT05840640","phase":"PHASE4","title":"Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2017-10-01","conditions":"Alcoholic Hepatitis","enrollment":66},{"nctId":"NCT03531502","phase":"NA","title":"Initial Management of Patients Receiving a Single Shock (IMPRESS)","status":"TERMINATED","sponsor":"Saint Luke's Health System","startDate":"2018-04-09","conditions":"Ventricular Tachycardia","enrollment":30},{"nctId":"NCT05807152","phase":"NA","title":"Furosemide-induced Diuresis With Matched Dehydration Compared to Standard Diuretic Therapy in Patients With Acute Heart Failure and Overt Fluid Overload","status":"UNKNOWN","sponsor":"Centro Cardiologico Monzino","startDate":"2019-02-19","conditions":"Acute Decompensated Heart Failure","enrollment":170},{"nctId":"NCT05769738","phase":"PHASE3","title":"The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2023-03","conditions":"Chronic Obstructive Pulmonary Disease Exacerbation, COPD Exacerbation","enrollment":200},{"nctId":"NCT05217342","phase":"PHASE4","title":"PVP-Guided Decongestive Therapy in HF","status":"UNKNOWN","sponsor":"Marmara University","startDate":"2022-01-01","conditions":"Heart Failure, Edema, Volume Overload","enrollment":586},{"nctId":"NCT04778787","phase":"PHASE4","title":"Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2021-01-01","conditions":"Congestive Heart Failure","enrollment":370},{"nctId":"NCT05633758","phase":"PHASE2","title":"Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Scripps Health","startDate":"2014-03","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT05430243","phase":"PHASE2, PHASE3","title":"Empagliflozin as a Novel Therapy in Refractory Ascites","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-04-21","conditions":"Ascites Hepatic","enrollment":42},{"nctId":"NCT04882358","phase":"NA","title":"Safety & Feasibility of DSR TherApy in Heart FAiluRe pAtients With Persistent Congestion","status":"UNKNOWN","sponsor":"Sequana Medical N.V.","startDate":"2021-05-27","conditions":"Heart Failure, Volume Overload","enrollment":24},{"nctId":"NCT04129840","phase":"NA","title":"Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-03-05","conditions":"Arterial Hypertension","enrollment":1268},{"nctId":"NCT01990911","phase":"NA","title":"Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study","status":"COMPLETED","sponsor":"Pace Clinic","startDate":"2013-03","conditions":"Hypertension, Hypertensive Heart Disease, Atrial Fibrillation","enrollment":80},{"nctId":"NCT04209140","phase":"","title":"Optimizing Response to Li Treatment Through Personalized Evaluation of Individuals With Bipolar I Disorder: The R-LiNK Initiative","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-01-10","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT05352633","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-07-18","conditions":"Blood Pressure","enrollment":710},{"nctId":"NCT03959930","phase":"NA","title":"Transdermal Fluid Removal in Fluid Overload","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2020-11-11","conditions":"Heart Failure, Odema","enrollment":22},{"nctId":"NCT04877652","phase":"","title":"DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics","status":"COMPLETED","sponsor":"Revamp Medical Ltd.","startDate":"2021-11-17","conditions":"Acute Decompensated Heart Failure","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard diuretic therapy","genericName":"Standard diuretic therapy","companyName":"University of Parma","companyId":"university-of-parma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard diuretic therapy increases urine output and reduces fluid volume in the body by inhibiting sodium and water reabsorption in the kidneys. Used for Hypertension, Edema associated with heart failure, liver cirrhosis, or renal disease, Congestive heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}